| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DB11-0004 |
| P8608 | Fatcat ID | release_wlv4do547jgttn2pxbywss6mvu |
| P932 | PMC publication ID | 3161332 |
| P698 | PubMed publication ID | 21715553 |
| P5875 | ResearchGate publication ID | 51454131 |
| P50 | author | Dana Philpott | Q63991698 |
| Amira Klip | Q64974771 | ||
| Adria Giacca | Q80162695 | ||
| P2093 | author name string | Zhi Liu | |
| Jonathan D Schertzer | |||
| Gregory R Steinberg | |||
| Morgan D Fullerton | |||
| Philip J Bilan | |||
| Akhilesh K Tamrakar | |||
| Sandra Pereira | |||
| Joao G Magalhães | |||
| P2860 | cites work | Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin | Q24539124 |
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis | Q28510028 | ||
| Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 | ||
| Thioredoxin-interacting protein links oxidative stress to inflammasome activation | Q29614471 | ||
| Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Q29615053 | ||
| Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice | Q29615055 | ||
| Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling | Q29616024 | ||
| The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance | Q29616026 | ||
| Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function | Q29616104 | ||
| TLR4 links innate immunity and fatty acid-induced insulin resistance | Q29617577 | ||
| Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan | Q29618544 | ||
| AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance | Q33581151 | ||
| Cluster analysis of insulin action in adipocytes reveals a key role for Akt at the plasma membrane | Q33593816 | ||
| Nutrient sensing and inflammation in metabolic diseases | Q33623354 | ||
| Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice | Q33687009 | ||
| Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes | Q33719311 | ||
| Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis | Q33869737 | ||
| Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition | Q34166263 | ||
| Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity. | Q34333517 | ||
| Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes | Q34594406 | ||
| Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion | Q35087584 | ||
| Innate immune recognition of microbes through Nod1 and Nod2: implications for disease | Q35781368 | ||
| Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance | Q36793492 | ||
| AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle. | Q52573139 | ||
| T-ing up inflammation in fat | Q58197131 | ||
| Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates | Q68161753 | ||
| The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity | Q36931760 | ||
| Nod-like proteins in inflammation and disease. | Q37045747 | ||
| Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis | Q37344018 | ||
| The development of a metabolic disease phenotype in CTP:phosphoethanolamine cytidylyltransferase-deficient mice | Q37377657 | ||
| NIH experiment in centralized mouse phenotyping: the Vanderbilt experience and recommendations for evaluating glucose homeostasis in the mouse | Q37391778 | ||
| The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation | Q37627659 | ||
| NOD2 Activation Induces Muscle Cell-Autonomous Innate Immune Responses and Insulin Resistance | Q39647567 | ||
| Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells | Q39931558 | ||
| Differential modulation of Nods signaling pathways by fatty acids in human colonic epithelial HCT116 cells | Q40170522 | ||
| Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity | Q41171975 | ||
| Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes | Q41828178 | ||
| Hepatocytes express functional NOD1 and NOD2 receptors: a role for NOD1 in hepatocyte CC and CXC chemokine production | Q42450600 | ||
| Intracellular delivery of phosphatidylinositol (3,4,5)-trisphosphate causes incorporation of glucose transporter 4 into the plasma membrane of muscle and fat cells without increasing glucose uptake | Q42828593 | ||
| Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. | Q42924282 | ||
| Energy intake is associated with endotoxemia in apparently healthy men. | Q45769895 | ||
| Nod2-dependent Th2 polarization of antigen-specific immunity. | Q46239376 | ||
| Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo | Q46939071 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| preproinsulin | Q7240673 | ||
| P1104 | number of pages | 10 | |
| P304 | page(s) | 2206-2215 | |
| P577 | publication date | 2011-06-29 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | NOD1 activators link innate immunity to insulin resistance | |
| P478 | volume | 60 |
| Q38924578 | "Weighing" the effects of exercise and intrinsic aerobic capacity: are there beneficial effects independent of changes in weight? |
| Q99586405 | A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity |
| Q37235428 | Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance |
| Q42810594 | Activation of nucleotide oligomerization domain containing protein 1 induces lipolysis through NF-κB and the lipolytic PKA activation in 3T3-L1 adipocytes |
| Q39015672 | Activation of pattern recognition receptors in brown adipocytes induces inflammation and suppresses uncoupling protein 1 expression and mitochondrial respiration. |
| Q30241406 | Adipose tissue macrophage in immune regulation of metabolism. |
| Q53841619 | Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics. |
| Q41339839 | Angiotensinogen gene silencing reduces markers of lipid accumulation and inflammation in cultured adipocytes. |
| Q35168603 | Bacterial peptidoglycan stimulates adipocyte lipolysis via NOD1. |
| Q34130570 | CD14 deficiency impacts glucose homeostasis in mice through altered adrenal tone |
| Q41275569 | Caspase-12, but Not Caspase-11, Inhibits Obesity and Insulin Resistance. |
| Q47736224 | Chronic activation of pattern recognition receptors suppresses brown adipogenesis of multipotent mesodermal stem cells and brown pre-adipocytes |
| Q34150760 | Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes |
| Q35225740 | Crystal structure of a complex of NOD1 CARD and ubiquitin |
| Q39135463 | Deconstructing metabolic inflammation using cellular systems |
| Q35192440 | Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance |
| Q35945260 | Different Th17 immunity in gut, liver, and adipose tissues during obesity: the role of diet, genetics, and microbes |
| Q26773256 | Effect of the Gut Microbiota on Obesity and Its Underlying Mechanisms: an Update |
| Q39154989 | Effects of genetic variations in the genes encoding NOD1 and NOD2 on type 2 diabetes mellitus and insulin resistance. |
| Q35881106 | Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up |
| Q27027464 | Fat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysis |
| Q57799919 | Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice |
| Q52694266 | Flavonoid-rich extract of Chromolaena odorata modulate circulating GLP-1 in Wistar rats: computational evaluation of TGR5 involvement. |
| Q29616815 | Functional interactions between the gut microbiota and host metabolism |
| Q90362845 | Gut Microbiome Toxicity: Connecting the Environment and Gut Microbiome-Associated Diseases |
| Q92209913 | Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD) |
| Q42351778 | Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice |
| Q40234158 | Habitual physical activity protects against lipopolysaccharide-induced inflammation in mouse adipose tissue |
| Q35999905 | High-intensity exercise training increases the diversity and metabolic capacity of the mouse distal gut microbiota during diet-induced obesity |
| Q27334019 | Identification of selective small molecule inhibitors of the nucleotide-binding oligomerization domain 1 (NOD1) signaling pathway |
| Q27500365 | Implication of inflammatory signaling pathways in obesity-induced insulin resistance |
| Q42478019 | Increased NOD1, but not NOD2, activity in subcutaneous adipose tissue from patients with metabolic syndrome |
| Q39148436 | Innate immune receptors in skeletal muscle metabolism. |
| Q92025173 | Intestinal Microbiota Contributes to Energy Balance, Metabolic Inflammation, and Insulin Resistance in Obesity |
| Q92761747 | Intestinal lysozyme liberates Nod1 ligands from microbes to direct insulin trafficking in pancreatic beta cells |
| Q26785561 | Is immunity a mechanism contributing to statin-induced diabetes? |
| Q35725309 | Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? |
| Q36964504 | Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet |
| Q38815129 | Lysyl oxidase propeptide promotes adipogenesis through inhibition of FGF-2 signaling |
| Q37173378 | Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism |
| Q30353335 | Metagenome and metabolism: the tissue microbiota hypothesis. |
| Q28075968 | Metainflammation in Diabetic Coronary Artery Disease: Emerging Role of Innate and Adaptive Immune Responses |
| Q54967145 | MicroRNA-495 inhibits the high glucose-induced inflammation, differentiation and extracellular matrix accumulation of cardiac fibroblasts through downregulation of NOD1. |
| Q91565214 | Microbiota guides insulin trafficking in beta cells |
| Q36232117 | Microbiotes and metabolic diseases: the bases for therapeutic strategies |
| Q38056233 | Molecular pathways linking metabolic inflammation and thermogenesis. |
| Q99238206 | NLR and Intestinal Dysbiosis-Associated Inflammatory Illness: Drivers or Dampers? |
| Q38171221 | NOD proteins: regulators of inflammation in health and disease |
| Q33774237 | NOD1 deficiency impairs CD44a/Lck as well as PI3K/Akt pathway |
| Q97681333 | NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet |
| Q38984265 | NOD1 receptor is up-regulated in diabetic human and murine myocardium. |
| Q41138874 | NOD1, a new player in cardiac function and calcium handling. |
| Q91933841 | NOD1: An Interface Between Innate Immunity and Insulin Resistance |
| Q44784362 | NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy |
| Q98954089 | Nucleotide-binding oligomerization domain protein 1 enhances oxygen-glucose deprivation and reperfusion injury in cortical neurons via activation of endoplasmic reticulum stress-mediated autophagy |
| Q34486744 | Orthologs of human disease associated genes and RNAi analysis of silencing insulin receptor gene in Bombyx mori |
| Q90468708 | Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases |
| Q52732929 | Peptidoglycan recognition by the innate immune system. |
| Q41872777 | Phenotyping of Nod1/2 double deficient mice and characterization of Nod1/2 in systemic inflammation and associated renal disease |
| Q47446607 | Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. |
| Q38182454 | Potential role of omega-3-derived resolution mediators in metabolic inflammation. |
| Q34182705 | Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects |
| Q38048563 | Regulation of metabolism: a cross talk between gut microbiota and its human host |
| Q90396914 | Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes |
| Q26864035 | Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases |
| Q34657137 | Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. |
| Q47753546 | Subcutaneous inguinal white adipose tissue is responsive to, but dispensable for, the metabolic health benefits of exercise |
| Q34315625 | Symptomatic atherosclerosis is associated with an altered gut metagenome |
| Q59806241 | Targeting macrophage scavenger receptor 1 promotes insulin resistance in obese male mice |
| Q36101136 | The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue |
| Q90040737 | The Intestine of Drosophila melanogaster: An Emerging Versatile Model System to Study Intestinal Epithelial Homeostasis and Host-Microbial Interactions in Humans |
| Q50985315 | The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice. |
| Q91089920 | The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis |
| Q51191309 | The Role of the p38-MNK-eIF4E Signaling Axis in TNF Production Downstream of the NOD1 Receptor. |
| Q22242038 | The antidiabetic gutsy role of metformin uncovered? |
| Q92460937 | The intestinal microbiota fuelling metabolic inflammation |
| Q31141977 | The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes |
| Q89754348 | The microbiome-adipose tissue axis in systemic metabolism |
| Q36994006 | The role of gut microbiota on insulin resistance |
| Q38016806 | Therapeutic modulation of microbiota-host metabolic interactions. |
| Q28676201 | Therapeutic targeting of NOD1 receptors |
| Q37631423 | Troxerutin Attenuates Enhancement of Hepatic Gluconeogenesis by Inhibiting NOD Activation-Mediated Inflammation in High-Fat Diet-Treated Mice |
| Q97643685 | Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity |
| Q38796867 | Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia |
| Q36976548 | Voluntary wheel running attenuates lipopolysaccharide-induced liver inflammation in mice |
Search more.